Sangamo and Pfizer to collaborate on Haemophilia A gene therapy
17 May 2017 | By Niamh Marriott, Junior Editor
Sangamo and Pfizer have announced a global collaboration and license agreement for the development of gene therapy programs for Haemophilia A...